A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma-Reference-Cited by-同舟云学术

A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma

Published:2015-07 Issue:7 Volume:17 Page:587-593
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Cho May,Wang‐Gillam Andrea,Myerson Robert,Gao Feng,Strasberg Steven,Picus Joel,Sorscher Steven,Fournier Chloe,Nagaraj Gayathri,Parikh Parag,Suresh Rama,Linehan David,Tan Benjamin R.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference25 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. Dramatic response to trastuzumab and paclitaxel in a patient with human epidermal growth factor receptor 2‐positive metastatic cholangiocarcinoma;Law;J Clin Oncol,2012

3. Cancer of the biliary system: a study of 445 cases;Shani;Br J Surg,1974

4. Primary carcinoma of the gallbladder;Hamrick;Ann Surg,1982

5. Cholangiocarcinoma;Yeo;Surg Clin North Am,1990

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant and adjuvant therapy for biliary tract cancer: Advances and limitations;Hepatology;2024-01-24

2. British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma;Gut;2023-09-28

3. A systematic study of novel drug delivery mechanisms and treatment strategies for pancreatic cancer;Journal of Drug Delivery Science and Technology;2021-06

4. Place de la radiothérapie des cholangiocarcinomes intra- et extrahépatiques;Cancer/Radiothérapie;2021-04

5. Efficacy Analysis of Adjuvant Chemotherapy with Gemcitabine Plus Platinum or S-1 in Biliary Tract Carcinoma: A Multi-Center Retrospective Study;Cancer Management and Research;2021-01